Roswell Park Comprehensive Cancer Center has earned its most highly rated grant from the National Cancer Institute (NCI). The NCI renewed Roswell Park’s status as a Comprehensive Cancer Center — a designation held by less than 4% of cancer centers — awarding Roswell Park the highest possible “Exceptional” rating as it renewed a grant Roswell Park has successfully competed for since 1972.

Data from a large prospective cohort study reveal that a polygenic risk score has the potential to predict survival outcomes in patients with breast cancer. Arya Mariam Roy, MBBS, Hematology/Oncology Fellow (Class of 2024) at Roswell Park Comprehensive Cancer Center, will share the results of that study as the first and presenting author of “Breast cancer polygenic risk score and patient survival outcomes in the Pathways study” at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, May 31-June 4.

Secondary analyses of a phase 3 clinical trial have revealed that breast cancer patients who reported high levels of pain and stress were more likely than their study peers to experience worse invasive disease-free survival (iDFS) and worse overall survival (OS). Shipra Gandhi, MD, MS, Associate Professor of Oncology in the Department of Medicine, Roswell Park Comprehensive Cancer Center, will discuss the study as first and presenting author of “Association of higher baseline stress and pain with clinical outcomes: Secondary analysis from Alliance A011502” at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, May 31-June 4.